Sentences with phrase «death of heart failure»

Years earlier, Lynda had filed a malpractice suit over her husband's sudden death of heart failure and won a modest settlement that included $ 93,500 to purchase annuities for both boys.

Not exact matches

This has resulted in a failure of the heart, which is indicated as the suspected cause of death,» prosecutors said in a statement,

«Among both groups, patients taking Entresto had a 20 % or greater reduction in cardiovascular death or heart failure hospitalization compared to those taking enalapril,» Novartis said in a statement, citing conclusions based on analysis of data from the PARADIGM - HF study.

[13] Personal communication 19.2.07 [14] Evans David, 2002, Brain death is a recent invention, BMJ 2002; 325:598, London [15] Deng Mario, 2000, Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity, Department of Cardiothoracic Surgery, Muenster University.

The coroner's report will likely show heart failure as the cause of death, which is common in coke junkies.

CKD patients in stage three to five are unable to manage potassium levels in the blood, putting them at risk of heart failure and death.

WASH chair and Queen Mary professor of cardiology Graham MacGregor said: «Eating too much salt puts up our blood pressure, the major cause of strokes, heart attacks and heart failure, the leading cause of death and disability worldwide.

Sharon and Dan Firlit felt the sting of their dog Bandit's death when he died last month after a long struggle with congestive heart failure.

So users may embark on the slow death of addiction or death from stroke heart attack or other organ failure and the number of overdose deaths involving methamphetamine have doubled in just two years,» said Jaquith.

No 10 issued a brief statement in response to the news of his death from heart failure last night.

Part - funded by the British Heart Foundation, the study shows that drinking more alcohol is associated with a higher risk of stroke, fatal aneurysm, heart failure and dHeart Foundation, the study shows that drinking more alcohol is associated with a higher risk of stroke, fatal aneurysm, heart failure and dheart failure and death.

But the No. 1 cause of death in people who are starving is heart failure due to extreme tissue and organ damage.

The results showed some correction of muscles throughout the body, including in the heart — a major victory because heart failure is often the cause of death for Duchenne patients.

A late - breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump functHeart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump funFailure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump functHeart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump functheart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump funfailure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump functheart failure and preserved ejection fraction (pump funfailure and preserved ejection fraction (pump function).

It is associated with an increased risk of stroke, heart failure and death.

Cardiac function assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury and help physicians select a prophylactic therapeutic strategy against sudden cardiac death in hemodialysis patients.»

Heart failure in children is an important cause of childhood health problems and death.

Graham's group found that people taking Avandia had about an 18 % higher risk of heart attack, stroke, heart failure, or death compared with those on Actos, which other work has shown is just as effective.

«Heart failure is a major medical problem with a high chance of hospitalisation and death,» said Dr Gho.

«Although the link between traffic - related air pollution and left ventricular hypertrophy, heart failure, and cardiovascular death is established, the effects of traffic - related air pollution on the right ventricle have not been well studied,» said lead author Peter Leary, MD, MS, of the University of Washington Medical Center in Seattle.

Previous studies have found an increase in heart - failure - related death among obese patients and also have reported that increased body fat can cause unfavorable changes in the shape and performance of the heart.

Death from heart failure can often be attributed to direct cardiac causes such as heart failure symptoms, inadequate blood supply and irregular heartbeats; however, the noncardiac causes of heart failure death, such as cancer, are becoming increasingly recognized as researchers learn more about their association with the disDeath from heart failure can often be attributed to direct cardiac causes such as heart failure symptoms, inadequate blood supply and irregular heartbeats; however, the noncardiac causes of heart failure death, such as cancer, are becoming increasingly recognized as researchers learn more about their association with the disdeath, such as cancer, are becoming increasingly recognized as researchers learn more about their association with the disease.

Cardiovascular disease remains the number one cause of death in the Western world, with heart failure representing the fastest - growing subclass over the past decade.

Findings from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitalization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of HeHeart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitalization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitalization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of Heheart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of Heheart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of HeHeart, Lung and Blood Institute, National Institutes of Health.

People with type 2 diabetes admitted to the hospital for heart failure faced a 24 to 28 percent chance of death during the remainder of the trial, on aloglipin or placebo respectively.

The study failed to meet both of its co-primary endpoints in that it did not show a significant benefit of steroid treatment over placebo in terms of either the overall rate of death or a composite metric that included death, heart attack, stroke, new renal failure or respiratory failure.

Study participants» control of individual and composite factors was also examined in relation to the occurrence of new cardiovascular events (including heart attacks, coronary deaths, strokes, heart failure, percutaneous interventions and bypass surgeries) over an average follow - up of 11 years.

CSA is a comorbidity in approximately 35 % of heart failure patients and doubles the risk of death.

Mitochondrial diseases affect the batteries of the cell and can lead to muscular weakness, blindness, fatal heart failure, learning disability, liver failure, diabetes and can lead to death in early infancy.

We get heavily hyped drugs like Avastin, which shrank tumors without adding significant time to cancer patients» lives (and increased the incidence of heart failure and blood clots to boot); Avandia, which lowered blood sugar in diabetics but raised the average risk of heart attack by 43 percent; torcetrapib, which raised both good cholesterol and death rates; and Flurizan, which reduced brain plaque but failed to slow the cognitive ravages of Alzheimer's disease before trials were finally halted in 2008.

It is difficult to diagnose and, without treatment, 25 percent of children with KD develop coronary artery aneurysms — balloon - like bulges of heart vessels — that may eventually result in heart attacks, congestive heart failure or sudden death.

To investigate, Csaba Kovesdy, MD (Memphis VA Medical Center and the University of Tennessee Health Science Center) and his colleagues examined information from the national VA research database and looked for associations between blood pressure and various clinical outcomes — coronary heart disease, stroke, kidney failure, and death — in more than 300,000 patients with CKD.

DCM is a disease characterized by progressive weakening and enlargement of the heart muscle, which can lead to heart failure and premature death.

• Systolic blood pressure levels above 140 mmHg were linked with higher risks of coronary heart disease, stroke, kidney failure, and death in patients with CKD of all ages, but the magnitude of these associations diminished with more advanced age.

A large randomized controlled trial of ischemic postconditioning in patients who had experienced the deadliest form of heart attack — ST - segment elevation myocardial infarction (STEMI)-- failed to show that this procedure significantly reduces death from any cause or hospitalization for heart failure, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

The primary endpoint was a composite of death from any cause and hospitalization for heart failure.

After an average follow - up time of 43 months, 105 patients or 17 percent in the DEFER group and 109 or 18 percent in the standard treatment group met the primary endpoint, a composite of death from any cause, hospitalization for heart failure, a second heart attack, and unplanned repeat angioplasty, a nonsignificant difference.

Delayed or deferred stent implantation in patients experiencing the deadliest form of heart attack — ST - segment elevation myocardial infarction (STEMI)-- failed to reduce death from any cause, hospitalization for heart failure, subsequent heart attacks or the need for a repeat procedure to restore blood flow to the heart, researchers reported at the American College of Cardiology's 65th Annual Scientific Session.

Heart failure is a debilitating condition that causes fatigue, shortness of breath, organ damage, and early death.

The new study, a post-hoc analysis, follows the main WARCEF study published in 2012 in the New England Journal of Medicine, finding neither aspirin nor warfarin superior for preventing a combined risk of death, stroke, and cerebral hemorrhage in heart failure patients with normal heart rhythm.

An analysis of the clinical trials suggests that ACEIs reduce the risk of death from all causes by 13 percent, cut the risk CV deaths by 17 percent and lower the risk of major CV events by 14 percent, including myocardial infarction (heart attack) by 21 percent and heart failure by 19 percent.

The findings, which appear online in the journal Heart Failure, underscore the importance of targeting prevention efforts at the earliest HF stages to avoid death.

ARBS did not affect all - cause mortality, CV death rate and major CV events, with the exception of heart failure.

There were also nine hospitalizations for hypertensive emergency (1.0 percent), eight for atrial fibrillation (0.9 percent), eight strokes (0.9 percent), six hospitalizations for new onset heart failure (0.7 percent), five heart attacks (0.6 percent), four deaths (0.4 percent) and two cases of new onset end stage kidney disease (0.2 percent) that were considered unrelated to the procedure.

The death of a partner is linked to a heightened risk of developing an irregular heartbeat otherwise known as atrial fibrillation — itself a risk factor for stroke and heart failure — for up to a year afterwards, finds research published in the online journal Open Hheart failure — for up to a year afterwards, finds research published in the online journal Open HeartHeart.

To determine whether scientific studies since 2002 found additional evidence on the usefulness of omega - 3 fish oil supplements, the authors focused on studies related to preventing a first heart attack in the general population, or in patients who were at high risk for heart disease, and preventing recurrent events and death in patients who had a prior heart attack, congestive heart failure, stroke, or atrial fibrillation.

Fibrotic diseases, such as chronic kidney disease and failure, lung disease, heart failure and cirrhosis of the liver, are estimated to be responsible for up to 45 percent of deaths in the developed world.

«Aspirin lowers risk of early death for patients with diabetes, heart failure: Paradoxically, aspirin also associated with increased risk of nonfatal heart attack, stroke.»

Can anything prevent the mysterious heart failures that cause sudden death in thousands of young athletes each year?

Results of one of the largest studies of heart failure to date show that warfarin is no better than aspirin in reducing the combined risks of brain hemorrhage, stroke and death in most heart failure patients.